|Full Name||v-akt murine thymoma viral oncogene homolog 1|
|Product Description||Rabbit Polyclonal antibody to AKT1 (phospho Ser129) (v-akt murine thymoma viral oncogene homolog 1)|
|Background||The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq]|
|Cellular Localization||Cytoplasm , Nucleus , Cell membrane|
|Target||AKT1 (phospho Ser129)|
|Immunogen||Carrier-protein conjugated synthetic peptide encompassing a sequence within the center region of human AKT1 (phospho Ser129). The exact sequence is proprietary.|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Mouse, Xenopus laevis, Cat, Chicken, Rhesus Monkey|
|Predict Reactivity Note||Mouse (100%), Xenopus laevis (100%), Cat (100%), Chicken (100%), Rhesus Monkey (100%)|